Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity

SIMPLE SUMMARY: Multiple myeloma is a bone marrow cancer that represents a severe health threat. The drugs used nowadays in chemotherapy often encounter resistance leading to a dramatic loss of their efficacy, which consequently affects patients’ survival. Previous studies have shown that the protei...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Bagratuni, Tina, Patseas, Dimitrios, Mavrianou-Koutsoukou, Nefeli, Liacos, Christine Ivy, Sklirou, Aimilia D., Rousakis, Pantelis, Gavriatopoulou, Maria, Terpos, Evangelos, Tsitsilonis, Ourania E., Trougakos, Ioannis P., Kastritis, Efstathios, Dimopoulos, Meletios A.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7601861/
https://ncbi.nlm.nih.gov/pubmed/33028016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102864
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados